{"id":"W2946496187","doi":"10.1111/hiv.12755","title":"Planning <scp>HIV</scp> therapy to prevent future comorbidities: patient years for tenofovir alafenamide","year":2019,"lang":"en","type":"review","venue":"HIV Medicine","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Tenofovir alafenamide; Medicine; Atazanavir; Ritonavir; Cobicistat; Lopinavir; Population; Internal medicine; Abacavir; Tolerability; Viral load; Adverse effect; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002992779,0.0006704984,0.002591697,0.0005216068,0.0001656921,0.00001340895,0.0002774875,0.0004560388,0.0001087504],"category_scores_gemma":[0.0001655944,0.0004525054,0.0004139483,0.0004829596,0.00007195676,0.00003900243,0.00006359234,0.0006302365,0.0008352599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004223884,"about_ca_system_score_gemma":0.0006788537,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002069296,"about_ca_topic_score_gemma":0.000001513963,"domain_scores_codex":[0.9967047,0.0001144213,0.001164302,0.0007825583,0.0005501274,0.0006838975],"domain_scores_gemma":[0.9968774,0.0007158873,0.0005582203,0.001088422,0.0001816615,0.0005783511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003056979,0.0004092754,0.00005086064,0.01027626,0.0006482902,0.00007799712,0.002542622,0.000004402941,8.805435e-7,0.000202034,0.3629361,0.6228207],"study_design_scores_gemma":[0.002142657,0.001848244,0.000202365,0.03786462,0.001241089,0.0001364961,0.0005384431,0.00001392945,6.86912e-7,0.00002478186,0.9558322,0.0001545239],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001498901,0.9845933,0.0001960117,0.002449177,0.001036879,0.007893979,0.0004788306,0.0001341084,0.003067804],"genre_scores_gemma":[0.00002597467,0.9792466,0.0009815139,0.001894539,0.00175632,0.001673895,0.004310449,0.0001795585,0.009931123],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6226662,"threshold_uncertainty_score":0.9999427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07318189554706622,"score_gpt":0.3872819198777135,"score_spread":0.3141000243306473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}